Once you know your peptide concentration in mg/mL, multiply by 0.01 to find how many milligrams are in each syringe unit
The FLOW trial (N=3,533), published in the New England Journal of Medicine in 2024, showed that semaglutide 1.0 mg reduced the composite kidney endpoint by 24% in patients with type 2 diabetes and chronic kidney disease compared to placebo [8], but the trial population was closely monitored
Understanding GLP Drugs: What They Are and Why People Take Them We have probably all seen the recent press on GLP drugs, or glucagon-like peptide-1 receptor agonists
Additionally, monocyte and macrophage marker cluster of differentiation 68 (Cd68) and monocyte chemoattractant protein-1 (Mcp-1) levels were lowered when treated with GIPR/GLP1R agonists
Your body has an incredible capacity to regulate itself when given the right tools, and these GLP-1-supporting foods are precisely those tools